National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 46633 [E8-18270]
Download as PDF
Federal Register / Vol. 73, No. 155 / Monday, August 11, 2008 / Notices
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Katrina L. Foster, PhD,
Scientific Review Administrator, National
Institute on Alcohol Abuse & Alcoholism,
National Institutes of Health, 5635 Fishers
Lane, Rm. 3042 Rockville, MD 20852, 301–
443–4032, katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: July 31 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–18254 Filed 8–8–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: July 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–18253 Filed 8–8–08; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
rmajette on PRODPC74 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience Review
Subcommittee.
Date: November 13–14, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Beata Buzas, PhD,
Scientific Review Administrator, National
Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5635 Fishers
Lane, Rm 3041, Rockville, MD 20852, 301–
443–0800, bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
VerDate Aug<31>2005
15:22 Aug 08, 2008
Jkt 214001
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel NIAID Clinical Trial
Planning (R34) Grants (DMID).
Date: September 2, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Barney Duane Price, PhD,
Scientific Review Officer, Scientific Review
Program, DHHS/NIH/NIAID/DEA, Room
3139, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, (301) 451–2592,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel NIAID Clinical Trial
Planning (R34) Grants (DAIDS).
Date: September 2, 2008.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Barney Duane Price, PhD,
Scientific Review Officer, Scientific Review
Program, DHHS/NIH/NIAID/DEA, Room
3139, 6700B Rockledge Drive, MSC 7616,
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
46633
Bethesda, MD 20892–7616, 301–451–2592,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel Infectious Diseases,
Transmission in the Developing World.
Date: September 3, 2008.
Time: 10:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700 B
Rockledge Drive, 3259, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Edward W. Schroder, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID, NIH, Room 2156, 6700–B Rockledge
Drive, MSC 7616, Bethesda, MD 20892–7616,
(301) 496–2550.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–18270 Filed 8–8–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel, R13 Scientific Conference Grants.
Date: August 20, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Office of Scientific Review,
Building 45, Room 3AN18, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Margaret Weidman, PhD,
Scientific Review Officer, Office of Scientific
E:\FR\FM\11AUN1.SGM
11AUN1
Agencies
[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Page 46633]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18270]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel NIAID Clinical Trial Planning (R34)
Grants (DMID).
Date: September 2, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Barney Duane Price, PhD, Scientific Review
Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, Room 3139,
6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 451-2592,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel NIAID Clinical Trial Planning (R34)
Grants (DAIDS).
Date: September 2, 2008.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Barney Duane Price, PhD, Scientific Review
Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, Room 3139,
6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-
2592, pricebd@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel Infectious Diseases, Transmission
in the Developing World.
Date: September 3, 2008.
Time: 10:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700 B Rockledge Drive,
3259, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Edward W. Schroder, PhD, Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, NIAID, NIH, Room 2156, 6700-B Rockledge Drive, MSC 7616,
Bethesda, MD 20892-7616, (301) 496-2550.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-18270 Filed 8-8-08; 8:45 am]
BILLING CODE 4140-01-M